Carson Wealth (CWM LLC)
SCPH

Carson Wealth (CWM LLC)’s scPharmaceuticals SCPH Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-525
Closed -$3K – 5604
2025
Q3 		$3K Sell
525
-236
-31% -$1.21K ﹤0.01% 4935
2025
Q2 		$3K Buy
761
+712
+1,453% +$2.21K ﹤0.01% 4808
2025
Q1 		$0 Buy
49
+26
+113% +$85 ﹤0.01% 5177
2024
Q4 		$0 Sell
23
-669
-97% -$2.56K ﹤0.01% 5121
2024
Q3 		$3K Buy
692
+424
+158% +$2.05K ﹤0.01% 4316
2024
Q2 		$1K Buy
+268
New +$1.18K ﹤0.01% 4472

Carson Wealth (CWM LLC)'s SCPH Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 525 shares — an estimated $3K sold.

Carson Wealth (CWM LLC) first reported a position in SCPH in Q2 2024 and held it in 6 quarters. The position peaked at $3K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 525 scPharmaceuticals shares in Q4 2025, an estimated $3K.
  • Carson Wealth (CWM LLC) first reported a position in scPharmaceuticals in Q2 2024 and held it in 6 quarters.
  • Carson Wealth (CWM LLC)'s scPharmaceuticals position peaked at $3K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.